tiprankstipranks
Trending News
More News >
Lytix Biopharma AS (DE:6BG)
:6BG
Germany Market
Advertisement

Lytix Biopharma AS (6BG) Cash flow

Compare
1 Followers

Lytix Biopharma AS Cash Flow

DE:6BG's free cash flow for Q2 2025 was kr-17.53M. For the 2025 fiscal year, DE:6BG's free cash flow was decreased by kr25.65M and operating cash flow was kr-17.53M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
kr -70.37Mkr -95.97Mkr -52.63Mkr -44.61Mkr -24.35M
Investing Cash Flow
kr 24.69Mkr 29.73Mkr -49.35Mkr 138.00Kkr 0.00
Financing Cash Flow
kr 149.10Mkr -943.00Kkr -749.00Kkr 213.30Mkr 40.00M
End Cash Position
kr 130.79Mkr 27.36Mkr 94.55Mkr 197.28Mkr 28.45M
Free Cash Flow
kr -70.37Mkr -96.02Mkr -52.78Mkr -44.61Mkr -24.35M
Currency in NOK

Lytix Biopharma AS Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis